Can Africa's equity markets rebound from their ten-year low?

Two hard years for African equities

clock • 2 min read

2014 and 2015 have been unkind years for African equity investors with markets down -13% and -21% respectively, amid sustained pressure from the forces that have battered emerging and frontier since mid-2014, including dollar strength, weak commodity prices and economic deceleration across the developing world.

The biggest headwind affecting recent returns in African equities has been weakening currency. 2015's total negative returns were -21.8%, of which currency losses represented -15% (equivalent to 71% of total losses). As the commencement of the rate tightening cycle in the US continues to hurt capital from emerging and frontier markets, we have observed over the last 18 months an unprecedented synchronised collapse in FX exchange rates across Africa. Between 2000 and 2013, the average annual deprecation of African currencies was circa-3.5%. However, over the last 18 months currencie...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot